| 注册
首页|期刊导航|河南中医|基于NF-κB信号通路探讨乌梅丸联合消痔灵治疗慢性放射性直肠炎作用机制

基于NF-κB信号通路探讨乌梅丸联合消痔灵治疗慢性放射性直肠炎作用机制

马玉婷 杜燕红 杨德群

河南中医2024,Vol.44Issue(5):784-789,6.
河南中医2024,Vol.44Issue(5):784-789,6.DOI:10.16367/j.issn.1003-5028.2024.05.0145

基于NF-κB信号通路探讨乌梅丸联合消痔灵治疗慢性放射性直肠炎作用机制

Study on the Mechanism of Action of Mume Pill Combined with Xiaozhiling in the Treatment of Chronic Radiation Proctitis Based on NF-κB Signaling Pathway

马玉婷 1杜燕红 2杨德群3

作者信息

  • 1. 湖北中医药大学,湖北 武汉 430000
  • 2. 湖北中医药大学附属湖北省中医院,湖北 武汉 430000
  • 3. 湖北中医药大学,湖北 武汉 430000||湖北中医药大学附属湖北省中医院,湖北 武汉 430000
  • 折叠

摘要

Abstract

Mume Pill in the treatment of chronic radiation proctitis may inhibit the upstream regulatory point of nuclear factor kappa-B(NF-κB)signaling pathway transduction,down-regulate the phosphorylation of IκB protein,and then inhibit the activation of NF-κB.It can also down-regulate the expression of NF-κB in colon of immune colitis,inhibit the production of interleukin(IL)-1β,and reduce inflammatory response.Xiaozhiling(消痔灵,XZL)for enema in the treatment of radiation proctitis can effectively reduce the level of inflammatory factors and improve clinical efficacy.Mume Pill combined with XZL has a certain effect on chronic radiation proctitis by inhibiting intestinal inflammatory response through NF-κB.However,at present,there are few studies on chronic radiation proctitis at home and abroad,the molecular structure is not clear,and the diagnosis and treatment lack unity.Moreover,Mume Pill has many compo-nents,and each drug has a variety of pharmacological effects,and the research mechanism is complex.In the future,animal experiments and evidence-based medicine research are needed to further verify the mechanism of action of XZL combined with Mume Pill in the treatment of chronic radiation proctitis.

关键词

乌梅丸/消痔灵/慢性放射性肠炎/NF-κB信号通路/《伤寒论》/张仲景

Key words

Mume Pill/Xiaozhiling(消痔灵,XZL)/chronic radiation enteritis/NF-κB signaling pathway/Treatise on Cold Damage Dis-eases/Zhang Zhongjing

分类

医药卫生

引用本文复制引用

马玉婷,杜燕红,杨德群..基于NF-κB信号通路探讨乌梅丸联合消痔灵治疗慢性放射性直肠炎作用机制[J].河南中医,2024,44(5):784-789,6.

基金项目

湖北省中医药管理局2023-2024年度中医药指导性项目(ZY2023F001) (ZY2023F001)

河南中医

1003-5028

访问量0
|
下载量0
段落导航相关论文